news_image.jpg

Best clinical practice

08 Aug 2018



The following consensus statement and clinical guideline have been developed with ESPE’s support:

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement Mantovani et al. 2018 Nature Reviews Endocrinology 14 476–500

Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline Hembree et al. 2017 Journal of Clinical Endocrinology & Metabolism 102 3869–3903

Remember, if you’d like ESPE to develop or endorse a new guideline, a member of our Clinical Practice Committee must be involved throughout the development process. More guidance for consensus meetings and guideline development is available on our website. 

See www.eurospe.org/clinical-practice/consensus-meeting-andguideline-development.



Issue 42 - Winter 2018

Latest Newsletter

Issue 42 - Winter 2018

Issue 42 - Winter 2018

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive